Literature DB >> 11161782

The transcription factor-like nuclear regulator (TFNR) contains a novel 55-amino-acid motif repeated nine times and maps closely to SMN1.

A R Kelter1, J Herchenbach, B Wirth.   

Abstract

The transcription factor-like nuclear regulator (TFNR) is a novel human gene that maps on 5q13, distal to the duplicated region that includes SMN1, the spinal muscular atrophy (SMA) determining gene. The location of TFNR allowed us to design an evolutionary model of the SMA region. The 9.5-kb TFNR transcript is highly expressed in cerebellum and weakly in all other tissues tested. TFNR encodes a protein of 2254 amino acids (aa) and contains nine repeats of a novel 55-aa motif, of yet unknown function. The coding region is organized in 32 exons. Alternative splicing of exon 15 results in a truncated protein of 796 aa. TFNR comprises a series of polypeptides that range from 55 to 250 kDa. Immunocytological studies showed that the TFNR protein is present exclusively in the nucleus, where it is concentrated in several nuclear structures. Amino acids 155-474 show significant homology to TFC5, a subunit of the yeast transcription factor TFIIIB, suggesting that TFNR is a putative transcription factor. Based on its proximity to SMN1 and its expression pattern, TFNR may be a candidate gene for atypical forms of SMA with cerebral atrophy and axonal neuropathy that have been shown to carry large deletions in the SMA region.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11161782     DOI: 10.1006/geno.2000.6396

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

1.  Different functional modes of p300 in activation of RNA polymerase III transcription from chromatin templates.

Authors:  Claudia Mertens; Robert G Roeder
Journal:  Mol Cell Biol       Date:  2008-07-21       Impact factor: 4.272

2.  Regulation of RNA polymerase III transcription during transformation of human IMR90 fibroblasts with defined genetic elements.

Authors:  Stéphanie Durrieu-Gaillard; Hélène Dumay-Odelot; Galina Boldina; Nicolas J Tourasse; Delphine Allard; Fabrice André; Françoise Macari; Armelle Choquet; Pauline Lagarde; Guillaume Drutel; Thierry Leste-Lasserre; Marion Petitet; Tom Lesluyes; Lydia Lartigue-Faustin; Jean-William Dupuy; Frédéric Chibon; Robert G Roeder; Dominique Joubert; Stéphan Vagner; Martin Teichmann
Journal:  Cell Cycle       Date:  2018-01-22       Impact factor: 4.534

Review 3.  Genomic relationship between SINE retrotransposons, Pol III-Pol II transcription, and chromatin organization: the journey from junk to jewel.

Authors:  Victoria V Lunyak; Michelle Atallah
Journal:  Biochem Cell Biol       Date:  2011-09-14       Impact factor: 3.626

Review 4.  Contributions of in vitro transcription to the understanding of human RNA polymerase III transcription.

Authors:  Hélène Dumay-Odelot; Stéphanie Durrieu-Gaillard; Leyla El Ayoubi; Camila Parrot; Martin Teichmann
Journal:  Transcription       Date:  2014

5.  Different sequence signatures in the upstream regions of plant and animal tRNA genes shape distinct modes of regulation.

Authors:  Gong Zhang; Radoslaw Lukoszek; Bernd Mueller-Roeber; Zoya Ignatova
Journal:  Nucleic Acids Res       Date:  2010-12-07       Impact factor: 16.971

Review 6.  Spatial organization of transcription by RNA polymerase III.

Authors:  Rebecca A Haeusler; David R Engelke
Journal:  Nucleic Acids Res       Date:  2006-09-13       Impact factor: 16.971

7.  Extracellular peptide Kratos restricts cell death during vascular development and stress in Arabidopsis.

Authors:  Sacha Escamez; Simon Stael; Julia P Vainonen; Patrick Willems; Huiting Jin; Sachie Kimura; Frank Van Breusegem; Kris Gevaert; Michael Wrzaczek; Hannele Tuominen
Journal:  J Exp Bot       Date:  2019-04-12       Impact factor: 6.992

8.  Human Maf1 negatively regulates RNA polymerase III transcription via the TFIIB family members Brf1 and Brf2.

Authors:  Janet Rollins; Ingrid Veras; Stephanie Cabarcas; Ian Willis; Laura Schramm
Journal:  Int J Biol Sci       Date:  2007-05-01       Impact factor: 6.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.